We believe that REPRO MED SYS INC (OOTC:REPR) can more than double from its recent trading price, but there are risks. The Company has been under a cloud since the FDA issued a warning letter concerning the company’s Freedom 60 Syringe […]
We believe that REPRO MED SYS INC (OOTC:REPR) can more than double from its recent trading price, but there are risks. The Company has been under a cloud since the FDA issued a warning letter concerning the company’s Freedom 60 Syringe […]